ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health policy"

  • Abstract Number: 1913 • ACR Convergence 2024

    Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review

    Mrinalini Dey1, Shyam Budhathoki2, Sofia Ramiro3, Kaleb Michaud4, Helen Elwell5, Sam Norton6, Maya H. Buch7, Andrew Cope1, Richard Osborne8, James Galloway9 and Elena Nikiphorou1, 1King's College London, London, United Kingdom, 2Imperial College London, London, United Kingdom, 3Leiden University Medical Center, Bunde, Netherlands, 4University of Nebraska Medical Center, Omaha, NE, 5British Medical Association, London, United Kingdom, 6King's College London, London, England, United Kingdom, 7Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, 8Swinburne University of Technology, Swinburne, Australia, 9Centre for Rheumatic Diseases, King's College London, London, United Kingdom

    Background/Purpose: Health literacy (HL) is a key social determinant of health in inflammatory arthritis (IA), including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, as it…
  • Abstract Number: 2158 • ACR Convergence 2024

    An MVPA Is MVPA Is MVPA, or Is It? Impact of the Definition of Moderate to Vigorous Physical Activity (MVPA) on Its Amount in Persons with Advanced Knee Osteoarthritis

    Samantha Chin1, Jamie Collins1, Jeffrey Katz2, Dorothy Dunlop3, Lauren Mitchell1, Rowland Chang4, Khara James1, Christine Pellegrini5, Jason Kim6, Katharine Fox1, Anne Holleman1 and Elena Losina1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Brookline, MA, 3Northwestern University, New Haven, CT, 4Northwestern University Division of Rheumatology, Chicago, IL, 5University of South Carolina, Columbia, SC, 6Arthritis Foundation, Atlanta, GA

    Background/Purpose: ActiGraph is a gold standard for MVPA assessment with several counts per minute (CPM) validated thresholds proposed to measure MVPA. Historically, these thresholds have…
  • Abstract Number: 2587 • ACR Convergence 2024

    A Proprietary AI Rule Engine Assisted by an OpenAI-based ML Model Can Speed up and Better Inform the Prior Authorization Process for Rheumatology Investigations and Medications

    Tanishka Agrawal1, Sumanth Raman2, J. Arun3 and HUMEIRA BADSHA4, 1Dubai International Academy, Dubai, Dubai, United Arab Emirates, 2Algorithm Health, Dubai, Dubai, United Arab Emirates, 3Algorithm Health, Dubai, United Arab Emirates, 4HBMC, Dubai, United Arab Emirates

    Background/Purpose: Patients with chronic autoimmune conditions often need expensive treatments which require prior authorizations by insurance companies. However, significant delays in these processes leave patients…
  • Abstract Number: 2610 • ACR Convergence 2024

    Treatment Concordance of Asynchronous Virtual Visits Compared to Traditional In-person Visits in Patients with Rheumatoid Arthritis: Results of the Prospective, Multi-center, Randomized Controlled TELERA Trial

    Johannes Knitza1, Johanna Mucke2, Manuel Grahammer3, Sebastian Kuhn1, Nicolas Vuillerme4, Felix Muehlensiepen5, Gerhard Krönke6, Georg Schett7, Ann-Christin Pecher8 and Martin Krusche9, and the TELERA Study Group, 1Institute for Digital Medicine, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany, Marburg, Germany, 2Heinrich-Heine-University, Duesseldorf, Germany, 3ABATON, Berlin, Germany, 4AGEIS, Université Grenoble Alpes, 38000 Grenoble, France, Grenoble, France, 5Center for Health Services Research, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany, Berlin, Germany, 6Rheumatology, Charité, Berlin, Germany, 7Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 8Interdisciplinary Center of Rheumatic Diseases (INDIRA), University Hospital Tuebingen, Tuebingen, Germany, Tübingen, Germany, 9III Department of Medicine, Division of Rheumatology and Systemic Inflammatory Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg, Germany

    Background/Purpose: Access to rheumatology care is becoming increasingly limited, necessitating a re-evaluation of patient pathways. The objective of this study was to evaluate a new…
  • Abstract Number: 0161 • ACR Convergence 2024

    Cross Country Burden of Osteoarthritis in Latin America and Caribbean from 1990-2021: A Comparative and Consistent Benchmarking Analysis for the Global Burden of Disease Study 2022

    malay rathod1, Eva Kalra2, Rafael Sanchez-Dopazo,3, Janmay Vala4, Saif Syed5, Akhilesh Sharma6, Ashwinikumar Shandilya7, Asmita Gera8, Mohit Lakkimsetti9, Juhi Patel10, VISHRANT AMIN11 and Hardik Desai12, 1Monmouth Medical Center, Rutgers University, Ewing, NJ, 2Trident Medical Cente, Charleston, SC, 3Larkin Community Hospital Palm Springs Campus, Hialeah, FL, 4Terna Medical College, Navi Mumbai, Maharashtra, India, 5Royal college of Surgeons,Dublin,Ireland, Dublin, Dublin, Ireland, 6Adesh Institute of Medical Sciences and Research, Bhatinda, India, 7Rural Medical college. Pravara institute of medical sciences., Ahmednagar, India, 8Tianjin medical University, Tianjin, China, Tianjin, Tianjin, China (People's Republic), 9Mamata Medical College,Khammam, Khammam, Telangana, India, 10GMERS MEDICAL COLLEGE VALSAD, 382330, Gujarat, India, 11GMERS MEDICAL COLLEGE VALSAD, Ahmedabad, India, 12Gujarat Adani Institute of Medical Sciences, Bhuj, India

    Background/Purpose: Osteoarthritis (OA) poses a significant and escalating health challenge across Latin America and the Caribbean (LAC), driven by demographic shifts, lifestyle factors, and varying…
  • Abstract Number: 0353 • ACR Convergence 2024

    Identifying Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus-Based Approach

    Joy Buie1, Michael Fisher1, Hannah Tlydsley2, Kristen Backor2 and Karen Costenbader3, 1Lupus Foundation of America, Washington, DC, 2Charles River Associates, San Francisco, CA, 3Brigham and Women's Hospital/ Harvard Medical School, Boston, MA

    Background/Purpose: Health disparities among racial and ethnic minoritized individuals living with lupus remain a critical public health concern. Challenges related to healthcare affordability, accessibility, and…
  • Abstract Number: 1046 • ACR Convergence 2024

    Shifting Paradigms in Drug Spending: A Study of Medicare Part D versus Emerging Pharmacy Models in Rheumatology

    Katherine Schoeffler, Stephanie Beveridge, Max Bouvette, Veera Durga Vaishnavi Kurra, Reema Moussa, Ryan Johnson, Camille Goerend, Nimrah Bader and Ryan Nipp, University of Oklahoma College of Medicine, Oklahoma City, OK

    Background/Purpose: Recent policy changes and competitive alternative drug pricing models present the potential for medication cost savings. In this study, we sought to assess the…
  • Abstract Number: 1049 • ACR Convergence 2024

    Very Low Uptake of Biosimilar Adalimumab in the First 9 Months of Availability in Rheumatology

    Eric Roberts1, Gabriela Schmajuk2 and Jinoos Yazdany3, 1University of California, San Francisco, SF, CA, 2UCSF / SFVA, San Francisco, CA, 3UCSF, San Francisco, CA

    Background/Purpose: In 2021, over 300,000 patients in the United States used adalimumab, making it one of the highest-grossing drugs globally. In 2023, patent exclusivity for…
  • Abstract Number: 1050 • ACR Convergence 2024

    The Cost-effectiveness of Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs) for Patients with Knee Osteoarthritis and Obesity

    Daniel Betensky1, Jeffrey Katz1, Catherine Yang2, David Hunter3, Jamie Collins1, Candace Feldman1, Karen Smith1, Stephen Messier4, Jason Kim5, Faith Selzer6 and Elena Losina1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Brookline, MA, 3Sydney Musculoskeletal Health, University of Sydney, St Leonards, New South Wales, Australia, 4Wake Forest University, Winston Salem, NC, 5Arthritis Foundation, Atlanta, GA, 6Brigham and Women's Hospital, Amesbury, MA

    Background/Purpose: Weight-loss has been shown to alleviate knee osteoarthritis (OA) symptoms in persons with OA and obesity. Utilization of GLP1RA medications has increased rapidly. These…
  • Abstract Number: 1880 • ACR Convergence 2024

    Statewide Burden of Osteoarthritis in India and Its Trend from 1990-2021: A Benchmarking Analysis

    Rafael Sanchez-Dopazo,1, malay rathod2, Ashwinikumar Shandilya3, Janmay Vala4, Eva Kalra5, Tapan Giri6, Saif Syed7, Mohit Lakkimsetti8, Juhi Patel9, VISHRANT AMIN10 and Hardik Desai11, 1Larkin Community Hospital Palm Springs Campus, Hialeah, FL, 2Monmouth Medical Center, Rutgers University, Ewing, NJ, 3Rural Medical college. Pravara institute of medical sciences., Ahmednagar, India, 4Terna Medical College, Navi Mumbai, Maharashtra, India, 5Trident Medical Cente, Charleston, SC, 6BJ Medical College, Pune, Pune, Maharashtra, India, 7Royal college of Surgeons,Dublin,Ireland, Dublin, Dublin, Ireland, 8Mamata Medical College,Khammam, Khammam, Telangana, India, 9GMERS MEDICAL COLLEGE VALSAD, 382330, Gujarat, India, 10GMERS MEDICAL COLLEGE VALSAD, Ahmedabad, India, 11Gujarat Adani Institute of Medical Sciences, Bhuj, India

    Background/Purpose: Osteoarthritis (OA) imposes a significant health burden globally, with India experiencing substantial demographic and epidemiological changes over the past three decades. This study addresses…
  • Abstract Number: 1882 • ACR Convergence 2024

    30-Day Readmission Among Patients with Rheumatoid Arthritis and Their Independent Predictors: Insights from National Readmission Database

    Shobhit Piplani1, Priyanshu Jain2, Vladimir Jelic3, Clement Tagoe4 and Beverly Johnson5, 1Jacobi Medical Center/North Central Bronx Albert Einstein College of Medicine NYC Health and Hospitals, Bronx, NY, 2Jawaharlal Nehru Medical College, Belgaum, Karnataka, India, Bronx, NY, 3Jacobi Medical Center/North Central Bronx, Bronx, NY, 4Albert Einstein College of Medicine, FRESH MEADOWS, NY, 5Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Rheumatoid Arthirits (RA) is associated with heightened morbidity, diminished quality of life, and increased healthcare expenses. This research aims to bridge this gap by…
  • Abstract Number: 0177 • ACR Convergence 2023

    Cost-Related Medication Non-Adherence Among US Adults with Chronic Arthritis: Trends, Comparisons, and Disparities

    Ashkan Ara1, Matthew Chenoweth1, Christopher Scannell2 and John FitzGerald1, 1University of California Los Angeles, Los Angeles, CA, 2UCLA / West Los Angeles VA Medical Center, Los Angeles, CA

    Background/Purpose: Cost-related medication non-adherence (CRN), a measure of drug affordability, refers to a patient's inability to adhere to a prescribed medication regimen due to high…
  • Abstract Number: 0198 • ACR Convergence 2023

    Improving Vaccination Uptake of Herpes Zoster in Young Rheumatic Disease Patients Ages 18-49 Using Specialty Pharmacy Partnership

    Stephen Lindsey1, Brittany Hill2, Sheela Sheth3 and Arya Loghmani2, 1LSU Health Science Center, New Orleans, LA, 2Louisiana State University, New Orleans, LA, 3Tulane University, New Orleans, LA

    Background/Purpose: Herpes zoster (HZ), also known as shingles, causes an estimated one million cases annually in the United States. Many studies have shown that the…
  • Abstract Number: 0217 • ACR Convergence 2023

    Safety and Efficacy of Tixagevimab/Cilgavimab (Evusheld) in Autoimmune Inflammatory Rheumatic Disease Patients – a Prospective Multicenter Open-label Study

    Tali Eviatar1, Victoria Furer2, Ilana Kaufman3, David levartovsky2, Ofir Elalouf2, Devy Zisman4, Tal Gazitt5, Amir Haddad4, Muna Elias6, Joy Feld7, Alexandra Balbir-Gurman8, Yolanda Braun Moscovici9, Sara Pel10, sharon Nevo11, Daphna Paran2 and Ori Elkayam2, 1Tel Aviv Sourasky Medical center, Ramat Gan, Israel, 2Tel Aviv Medical Center, Tel Aviv, Israel, 3Tel Aviv Medical Center, Petah-Tikva, Israel, 4Carmel Medical Center, Haifa, Israel, 5Carmel Hospital, Haifa, Israel, 6rheumatology unit, Haifa, Israel, 7Carmel and Zvulun Medical Centre, Haifa, Israel, 8Rheumatology Institute, Rambam Health Care Campus and Rappaport Faculty of |Medicine, Technion, Haifa, Israel, 9Rambam Heath Care Campus, Haifa, Israel, 10Tel Aviv Medical Center, Modiin, Israel, 11Tel Aviv Sourasky Medical Center, Givataim, Israel

    Background/Purpose: Autoimmune inflammatory rheumatic disease (AIIRD) patients treated with rituximab (RTX) are at risk for severe COVID19 infection, and a blunted humoral response to SARS-CoV-2…
  • Abstract Number: 0465 • ACR Convergence 2023

    The Effects of Post-Dobbs Abortion Policy on Rheumatology Clinical Practice: A Survey of Rheumatologists

    Mehret Birru Talabi1, Bonnie Bermas2, Irene Blanco3, Ashira Blazer4, Megan Clowse5, Cuoghi Edens6, Leslie Pierce7, Catherine Wright1 and Rosalind Ramsey-Goldman3, 1University of Pittsburgh, Pittsburgh, PA, 2UT Southwestern, Dallas, TX, 3Northwestern University, Chicago, IL, 4Hospital for Special Surgery, New York, NY, 5Duke University, Chapel Hill, NC, 6University of Chicago, Chicago, IL, 7University of Pittsburgh, Raleigh, NC

    Background/Purpose: In June 2022, the U.S. Supreme Court's decision in Dobbs v. Jackson Women's Health removed the federal constitutional right to abortion, returning abortion policy…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology